JNCI Cancer Spectrum · 2018 · 46 citations · 9 references
MedicineOncologyRadiologyCancer EpidemiologyCancer ScreeningEpidemiologyCancer MortalityCancer Survival AnalysisLung CancerMortality AnalysisDeath RatesLung Cancer EpidemiologyLung Cancer MortalityLung Cancer ScreeningScreening Chest RadiographyTrial Feasibility Assessment
The Lung Screening Study was a multicenter controlled feasibility trial that randomly assigned subjects to undergo two rounds of screening with either low-dose spiral computed tomography (LDCT) or chest X-ray (CXR). Long-term follow-up was performed to evaluate any differences in lung-cancer-specific and all-cause mortality between arms. In 2000, subjects were randomly assigned at six screening centers. Linkage with the National Death Index was performed to ascertain long-term mortality for subjects. Median follow-up for mortality of the 1660 and 1658 subjects randomly assigned to LDCT and CXR, respectively, was 5.2 years. There were 32 and 26 deaths from lung cancer in the two groups, respectively, corresponding to lung cancer death rates of 3.84 and 3.10 per 1000 person-years, and a risk ratio of 1.24 (95% confidence interval = 0.74 to 2.08). The risk ratio for all-cause mortality was 1.20 (95% confidence interval = 0.94 to 1.54). These findings can contribute to the overall knowledge on LDCT lung cancer screening.
9
Maurizio Infante, Silvio Cavuto, Romano Fabio Lutman et al. · American Journal of Respiratory and Critical Care Medicine · 2015 · 365 citations
Nodule management protocol of the NELSON randomised lung cancer screening trial
Dong Xu, Hester A. Gietema, Harry J. de Koning et al. · Lung Cancer · 2006 · 344 citations
Medicine, Oncology, Cancer Screening +11